OmniAb, Inc. (OABI)
2.15
-0.01
(-0.46%)
USD |
NASDAQ |
Dec 12, 16:00
2.155
0.00 (0.00%)
After-Hours: 20:00
OmniAb Profit Margin (Quarterly): -738.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -301.3% |
| GT Biopharma, Inc. | -- |
| Karyopharm Therapeutics, Inc. | -75.21% |
| Zevra Therapeutics, Inc. | -2.09% |
| Foghorn Therapeutics, Inc. | -194.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.86% |
| Return on Assets | -19.87% |
| Return on Invested Capital | -21.16% |
| Gross Profit Margin (Quarterly) | -109.2% |
| Operating Margin (Quarterly) | -811.3% |
| Return on Net Operating Assets | -24.83% |